PATENT CLAIM ANALYSIS

Application Number: 16028221
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "055000"]

Abstract:
The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders.

Claim (Index 2):
The viscoelastic glycated chitosan polymer, according to  claim 1 , which has a molecular weight of less than 500,000 Daltons.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 95.0
- Lexical Diversity: 1.36364
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13037171', '13755105', '10870342', '12404879', '13502818']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6984560496833899
- 35 USC 102 Novelty (BERT): 0.5021484616180026
- Combined Prediction Score: 0.6788252908768512
- Mean Citation Score: 151.17314
- Max Citation Score: 174.05624
- Similarity Product: 110.54799529571537

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test